XML 17 R5.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' DEFICIT - USD ($)
shares in Thousands, $ in Thousands
Ordinary Shares
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Total
Balances at Dec. 31, 2018 $ 1 $ 960,721 $ (166) $ (1,012,145) $ (51,589)
Balances (in shares) at Dec. 31, 2018 55,681        
Increase (Decrease) in Stockholders' Equity          
Proceeds from ESPP purchases   2,605     2,605
Proceeds from ESPP purchases (in shares) 145        
Employee share-based compensation expense   36,538     36,538
Issuance of restricted shares (in shares) 898        
Option exercises   2,973     2,973
Option exercises (in shares) 151        
Repurchase of shares to satisfy tax withholding   (2,743)     (2,743)
Repurchase of shares to satisfy tax withholding (in shares) (113)        
Net unrealized gain/loss on marketable securities     260   260
Net loss       (170,849) (170,849)
Balances at Sep. 30, 2019 $ 1 1,000,094 94 (1,182,994) (182,805)
Balances (in shares) at Sep. 30, 2019 56,762        
Balances at Jun. 30, 2019 $ 1 987,209 129 (1,124,563) (137,224)
Balances (in shares) at Jun. 30, 2019 56,637        
Increase (Decrease) in Stockholders' Equity          
Employee share-based compensation expense   13,019     13,019
Issuance of restricted shares (in shares) 209        
Option exercises   428     428
Option exercises (in shares) 29        
Repurchase of shares to satisfy tax withholding   (562)     (562)
Repurchase of shares to satisfy tax withholding (in shares) (113)        
Net unrealized gain/loss on marketable securities     (35)   (35)
Net loss       (58,431) (58,431)
Balances at Sep. 30, 2019 $ 1 1,000,094 94 (1,182,994) (182,805)
Balances (in shares) at Sep. 30, 2019 56,762        
Balances at Dec. 31, 2019 $ 1 1,024,614 145 (1,248,600) $ (223,840)
Balances (in shares) at Dec. 31, 2019 57,015       57,015
Increase (Decrease) in Stockholders' Equity          
Net proceeds from sale of ordinary shares   139,915     $ 139,915
Net proceeds from sale of ordinary shares (in shares) 5,500        
Proceeds from ESPP purchases   2,545     2,545
Proceeds from ESPP purchases (in shares) 168        
Employee share-based compensation expense   47,425     47,425
Issuance of restricted shares (in shares) 1,590        
Option exercises   960     960
Option exercises (in shares) 43        
Repurchase of shares to satisfy tax withholding   (8,935)     (8,935)
Repurchase of shares to satisfy tax withholding (in shares) (360)        
Net unrealized gain/loss on marketable securities     (23)   (23)
Net loss       (219,583) (219,583)
Balances at Sep. 30, 2020 $ 1 1,206,524 122 (1,468,183) $ (261,536)
Balances (in shares) at Sep. 30, 2020 63,956       63,956
Balances at Jun. 30, 2020 $ 1 1,191,923 280 (1,394,540) $ (202,336)
Balances (in shares) at Jun. 30, 2020 63,515        
Increase (Decrease) in Stockholders' Equity          
Employee share-based compensation expense   15,564     15,564
Issuance of restricted shares (in shares) 493        
Option exercises   24     24
Option exercises (in shares) 2        
Repurchase of shares to satisfy tax withholding   (987)     (987)
Repurchase of shares to satisfy tax withholding (in shares) (54)        
Net unrealized gain/loss on marketable securities     (158)   (158)
Net loss       (73,643) (73,643)
Balances at Sep. 30, 2020 $ 1 $ 1,206,524 $ 122 $ (1,468,183) $ (261,536)
Balances (in shares) at Sep. 30, 2020 63,956       63,956